Updates to our Terms of Use

We are updating our Terms of Use. Please carefully review the updated Terms before proceeding to our website.

Thursday, April 18, 2024 | Back issues
Courthouse News Service Courthouse News Service

Shareholders Class Action

Shareholders accuse directors or Penwest Pharmaceuticals of self-dealing, unjust enrichment and breach of duties in the proposed sale to Endo Pharmaceuticals, for $5 a share, or $168 million, in King County Court, Seattle.

Categories / Uncategorized

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.

Loading...